Clinical Research Enrollment
Grants (CRE)

Applications for the Clinical Research Enrollment Grant (CRE) are open for the 2011 grant cycle.

Download the CRE RFA.

Women, especially racial and ethnic minorities, are not adequately represented in cancer research efforts. Multiple barriers — cultural, linguistic, financial, and systematic — hinder their participation in clinical research, and particularly in clinical trials. Through Clinical Research Enrollment Grants, Komen Greater NYC seeks to fund projects that employ effective strategies to overcome these barriers to enrollment and retention in breast cancer clinical research.

To apply for a Komen Greater NYC Clinical Research Enrollment Grant, your organization must be:

1. A federally tax exempt entity — nonprofit organization, government agency, educational institution, or Indian tribe.
2. Conducting National Cancer Institute (NCI) or Department of Defense (DOD)-approved breast cancer clinical research, including studies sponsored by Clinical Trials Cooperative Groups (e.g., ACOSOG, ECOG, SWOG, NSABP, ACRIN, and RTOG). The proposed enrollment program may refer patients to non-NCI or DOD approved research studies supported by the applicant institution as long as NCI or DOD research is being conducted as well.
3. Located in the Komen Greater NYC service area — the five boroughs of New York City, Long Island, Westchester and Rockland Counties.

A Request for Applications (RFA) is now available. Deadline to apply is October 15 2010. Award notifications will be made in February 2011.

A project may be funded for up to two years. Organizations that have previously received Komen Greater NYC funding are welcome to apply for additional funding. However, please note that, if your organization began a Clinical Research Enrollment Grant in grant year 2010/2011, you are not eligible for consideration during the 2011/2012 granting cycle.

View How to Apply.